应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MNPR Monopar Therapeutics
休市中 04-26 16:00:00 EDT
0.6582
+0.0307
+4.89%
盘后
0.6730
+0.0148
+2.25%
19:30 EDT
最高
0.6671
最低
0.6300
成交量
3.50万
今开
0.6300
昨收
0.6275
日振幅
5.91%
总市值
1,149万
流通市值
547.18万
总股本
1,745万
成交额
2.27万
换手率
0.42%
流通股本
831.33万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Monopar Therapeutics Inc.盘中异动 快速下挫8.32%
自选股智能写手 · 04-19
Monopar Therapeutics Inc.盘中异动 快速下挫8.32%
Monopar Therapeutics Inc.盘中异动 早盘股价大跌5.22%报0.690美元
自选股智能写手 · 04-17
Monopar Therapeutics Inc.盘中异动 早盘股价大跌5.22%报0.690美元
Monopar Therapeutics Inc.盘中异动 早盘股价大跌5.96%
自选股智能写手 · 04-16
Monopar Therapeutics Inc.盘中异动 早盘股价大跌5.96%
Monopar Therapeutics Inc.盘中异动 股价大涨5.19%报0.810美元
自选股智能写手 · 04-13
Monopar Therapeutics Inc.盘中异动 股价大涨5.19%报0.810美元
Monopar Therapeutics Inc.盘中异动 快速上涨19.08%
自选股智能写手 · 04-11
Monopar Therapeutics Inc.盘中异动 快速上涨19.08%
JonesTrading:上调Monopar Therapeutics(MNPR.US)评级,由持有调整至买入评级, 目标价2.00美元。
智通财经 · 04-11
JonesTrading:上调Monopar Therapeutics(MNPR.US)评级,由持有调整至买入评级, 目标价2.00美元。
Monopar Therapeutics Inc.盘中异动 股价大跌6.17%报0.601美元
自选股智能写手 · 04-03
Monopar Therapeutics Inc.盘中异动 股价大跌6.17%报0.601美元
Monopar Therapeutics Inc.盘中异动 下午盘大幅跳水5.74%
自选股智能写手 · 04-03
Monopar Therapeutics Inc.盘中异动 下午盘大幅跳水5.74%
Monopar Therapeutics Inc.2023财年实现净利润-8.40百万美元,同比增加20.15%
自选股智能写手 · 03-30
Monopar Therapeutics Inc.2023财年实现净利润-8.40百万美元,同比增加20.15%
Monopar Therapeutics Inc.盘中异动 股价大跌7.63%
自选股智能写手 · 03-23
Monopar Therapeutics Inc.盘中异动 股价大跌7.63%
Monopar Therapeutics Inc 预计每股亏损 15 美分 - 财报前瞻
Reuters · 03-19
Monopar Therapeutics Inc 预计每股亏损 15 美分 - 财报前瞻
Monopar Therapeutics Inc.盘中异动 临近收盘急速跳水5.60%
自选股智能写手 · 03-15
Monopar Therapeutics Inc.盘中异动 临近收盘急速跳水5.60%
公司概况
公司名称:
Monopar Therapeutics
所属市场:
NASDAQ
上市日期:
--
主营业务:
Monopar Therapeutics Inc.最初于2014年12月5日在特拉华州注册成立,是一家有限责任公司,并于2015年12月16日通过免税交易所转换为C公司,当时该公司进行了1对10的反向股票分割。该公司是一家新兴的生物制药公司,致力于开发创新药物和药物组合,以改善癌症患者的临床结果。
发行价格:
--
{"stockData":{"symbol":"MNPR","market":"US","secType":"STK","nameCN":"Monopar Therapeutics","latestPrice":0.6582,"timestamp":1714161600000,"preClose":0.6275,"halted":0,"volume":35008,"hourTrading":{"tag":"盘后","latestPrice":0.673,"preClose":0.6582,"latestTime":"19:30 EDT","volume":602,"amount":408.148,"timestamp":1714174244634},"delay":0,"floatShares":8313346,"shares":17454925,"eps":-0.607799,"marketStatus":"休市中","marketStatusCode":7,"change":0.0307,"latestTime":"04-26 16:00:00 EDT","open":0.63,"high":0.6671,"low":0.63,"amount":22701.6657664,"amplitude":0.059124,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.607799,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714377600000},"adr":0,"listingDate":1576731600000,"adjPreClose":0.6275,"preHourTrading":{"tag":"盘前","latestPrice":0.6387,"preClose":0.628,"latestTime":"08:46 EDT","volume":121,"amount":79.6172014,"timestamp":1714135609484},"postHourTrading":{"tag":"盘后","latestPrice":0.673,"preClose":0.6582,"latestTime":"19:30 EDT","volume":602,"amount":408.148,"timestamp":1714174244634},"volumeRatio":0.715266},"requestUrl":"/m/hq/s/MNPR/wiki","defaultTab":"wiki","newsList":[{"id":"2428166880","title":"Monopar Therapeutics Inc.盘中异动 快速下挫8.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428166880","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428166880?lang=zh_cn&edition=full","pubTime":"2024-04-19 22:38","pubTimestamp":1713537538,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日22时38分,Monopar Therapeutics Inc.股票出现波动,股价大幅下跌8.32%。截至发稿,该股报0.622美元/股,成交量5638股,换手率0.03%,振幅3.79%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.44%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发专有疗法,旨在延长癌症患者的生命或改善生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192238587a5420c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404192238587a5420c8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428534591","title":"Monopar Therapeutics Inc.盘中异动 早盘股价大跌5.22%报0.690美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428534591","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428534591?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:31","pubTimestamp":1713360673,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时31分,Monopar Therapeutics Inc.股票出现波动,股价快速下跌5.22%。截至发稿,该股报0.690美元/股,成交量9794股,换手率0.06%,振幅0.00%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.67%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发专有疗法,旨在延长癌症患者的生命或改善生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417213113878a1219&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417213113878a1219&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427272698","title":"Monopar Therapeutics Inc.盘中异动 早盘股价大跌5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427272698","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427272698?lang=zh_cn&edition=full","pubTime":"2024-04-16 21:30","pubTimestamp":1713274257,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日21时30分,Monopar Therapeutics Inc.股票出现波动,股价大幅下挫5.96%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Palisade Bio, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Jaguar Health, Inc.涨幅较大,Palisade Bio, Inc.、Biorestorative Therapies, Inc.、Soligenix, Inc.较为活跃,换手率分别为818.93%、92.25%、27.34%,振幅较大的相关个股有Brainstorm Cell Therapeutics Inc.、Marinus Pharmaceuticals, Inc.、Immuron Limited,振幅分别为13.12%、7.69%、7.33%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发专有疗法,旨在延长癌症患者的生命或改善生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162130587a532d14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404162130587a532d14&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427372937","title":"Monopar Therapeutics Inc.盘中异动 股价大涨5.19%报0.810美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427372937","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427372937?lang=zh_cn&edition=full","pubTime":"2024-04-13 00:15","pubTimestamp":1712938555,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日00时15分,Monopar Therapeutics Inc.股票出现波动,股价快速拉升5.19%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.11%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发专有疗法,旨在延长癌症患者的生命或改善生活质量。该信息摘要如下:JonesTrading:上调Monopar Therapeutics评级,由持有调整至买入评级, 目标价2.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041300155687e7ffdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041300155687e7ffdf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426268933","title":"Monopar Therapeutics Inc.盘中异动 快速上涨19.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426268933","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426268933?lang=zh_cn&edition=full","pubTime":"2024-04-11 21:31","pubTimestamp":1712842305,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日21时31分,Monopar Therapeutics Inc.股票出现波动,股价快速上涨19.08%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.32%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发专有疗法,旨在延长癌症患者的生命或改善生活质量。该信息摘要如下:JonesTrading:上调Monopar Therapeutics评级,由持有调整至买入评级, 目标价2.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112131458767fa22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112131458767fa22&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426569902","title":"JonesTrading:上调Monopar Therapeutics(MNPR.US)评级,由持有调整至买入评级, 目标价2.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426569902","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426569902?lang=zh_cn&edition=full","pubTime":"2024-04-11 19:46","pubTimestamp":1712835968,"startTime":"0","endTime":"0","summary":"JonesTrading:上调Monopar Therapeutics(MNPR.US)评级,由持有调整至买入评级, 目标价2.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041119461387677de9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041119461387677de9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424845765","title":"Monopar Therapeutics Inc.盘中异动 股价大跌6.17%报0.601美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424845765","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424845765?lang=zh_cn&edition=full","pubTime":"2024-04-03 21:35","pubTimestamp":1712151332,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日21时35分,Monopar Therapeutics Inc.股票出现异动,股价急速下跌6.17%。截至发稿,该股报0.601美元/股,成交量6772股,换手率0.04%,振幅1.22%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.01%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发专有疗法,旨在延长癌症患者的生命或改善生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403213533861e3501&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403213533861e3501&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424073790","title":"Monopar Therapeutics Inc.盘中异动 下午盘大幅跳水5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424073790","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424073790?lang=zh_cn&edition=full","pubTime":"2024-04-03 02:24","pubTimestamp":1712082274,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日02时24分,Monopar Therapeutics Inc.股票出现异动,股价快速下挫5.74%。截至发稿,该股报0.640美元/股,成交量6.9586万股,换手率0.47%,振幅5.74%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.75%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发专有疗法,旨在延长癌症患者的生命或改善生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404030224347a50bb2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404030224347a50bb2d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2423169074","title":"Monopar Therapeutics Inc.2023财年实现净利润-8.40百万美元,同比增加20.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2423169074","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2423169074?lang=zh_cn&edition=full","pubTime":"2024-03-30 02:13","pubTimestamp":1711736016,"startTime":"0","endTime":"0","summary":"12月31日,Monopar Therapeutics Inc.公布财报,公告显示公司2023财年净利润为-8.40百万美元,同比增加20.15%;其中营业收入为0.00美元,每股基本收益为-0.61美元。机构评级:截至2023年12月31日,当前有1家机构对Monopar Therapeutics Inc.目标价做出预测,其中目标均价为15.00美元,其中最低目标价为15.00美元,最高目标价为15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024033002134687c64fdc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024033002134687c64fdc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421384925","title":"Monopar Therapeutics Inc.盘中异动 股价大跌7.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421384925","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421384925?lang=zh_cn&edition=full","pubTime":"2024-03-23 00:08","pubTimestamp":1711123724,"startTime":"0","endTime":"0","summary":"北京时间2024年03月23日00时08分,Monopar Therapeutics Inc.股票出现波动,股价急速下跌7.63%。截至发稿,该股报0.647美元/股,成交量5.9174万股,换手率0.40%,振幅4.30%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.01%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发专有疗法,旨在延长癌症患者的生命或改善生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403230008457a4e8d71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403230008457a4e8d71&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420222951","title":"Monopar Therapeutics Inc 预计每股亏损 15 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2420222951","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2420222951?lang=zh_cn&edition=full","pubTime":"2024-03-19 20:53","pubTimestamp":1710852802,"startTime":"0","endTime":"0","summary":" * Monopar Therapeutics Inc 预计在3月21日发布业绩报告时,季度营收将不会有任何变化(预计),截至2023年12月31日。* * LSEG 的分析师平均预计 Monopar Therapeutics Inc 每股亏损 15 美分。* 目前分析师对该公司股票的平均评级为 \"买入\",建议的细分为 1 个 \"强烈买入 \"或 \"买入\",1 个 \"持有\",没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Monopar Therapeutics Inc 的 12 个月目标价中值为 8.50 美元,高于其 0.67 美元的最新收盘价。3月19日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2419930561","title":"Monopar Therapeutics Inc.盘中异动 临近收盘急速跳水5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419930561","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419930561?lang=zh_cn&edition=full","pubTime":"2024-03-15 03:55","pubTimestamp":1710446119,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日03时55分,Monopar Therapeutics Inc.股票出现异动,股价大幅下挫5.60%。截至发稿,该股报0.710美元/股,成交量13.8119万股,换手率0.93%,振幅7.58%。Monopar Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.59%。Monopar Therapeutics Inc.公司简介:Monopar Therapeutics Inc 是一家临床阶段的生物制药公司,专注于开发专有疗法,旨在延长癌症患者的生命或改善生活质量。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031503551987e7902e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031503551987e7902e&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.monopartx.com","stockEarnings":[{"period":"1week","weight":0.0283},{"period":"1month","weight":-0.1069},{"period":"3month","weight":0.8097},{"period":"6month","weight":0.4309},{"period":"1year","weight":-0.4325},{"period":"ytd","weight":0.9347}],"compareEarnings":[{"period":"1week","weight":0.0265},{"period":"1month","weight":-0.0285},{"period":"3month","weight":0.0428},{"period":"6month","weight":0.2376},{"period":"1year","weight":0.2324},{"period":"ytd","weight":0.0693}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Monopar Therapeutics Inc.最初于2014年12月5日在特拉华州注册成立,是一家有限责任公司,并于2015年12月16日通过免税交易所转换为C公司,当时该公司进行了1对10的反向股票分割。该公司是一家新兴的生物制药公司,致力于开发创新药物和药物组合,以改善癌症患者的临床结果。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.132183},{"month":2,"riseRate":0.4,"avgChangeRate":0.185715},{"month":3,"riseRate":0,"avgChangeRate":-0.262897},{"month":4,"riseRate":0.2,"avgChangeRate":-0.066685},{"month":5,"riseRate":0.25,"avgChangeRate":-0.048967},{"month":6,"riseRate":0.5,"avgChangeRate":-0.012673},{"month":7,"riseRate":0,"avgChangeRate":-0.09892},{"month":8,"riseRate":0,"avgChangeRate":-0.116612},{"month":9,"riseRate":0,"avgChangeRate":-0.076656},{"month":10,"riseRate":0.25,"avgChangeRate":0.031802},{"month":11,"riseRate":0.5,"avgChangeRate":-0.066139},{"month":12,"riseRate":0.5,"avgChangeRate":0.019568}],"exchange":"NASDAQ","name":"Monopar Therapeutics","nameEN":"Monopar Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Monopar Therapeutics(MNPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Monopar Therapeutics(MNPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Monopar Therapeutics,MNPR,Monopar Therapeutics股票,Monopar Therapeutics股票老虎,Monopar Therapeutics股票老虎国际,Monopar Therapeutics行情,Monopar Therapeutics股票行情,Monopar Therapeutics股价,Monopar Therapeutics股市,Monopar Therapeutics股票价格,Monopar Therapeutics股票交易,Monopar Therapeutics股票购买,Monopar Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Monopar Therapeutics(MNPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Monopar Therapeutics(MNPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}